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Supplementary Figure 1. Replication of HIV-1 NL4.3-Bal in CD8-depleted activated PBMCs. Activated 
CD8-depleted PBMC were infected with HIV-1 NL4.3-Bal and cultured under 20% or 1% O2 
conditions and viral replication was assessed at 0, 2 and 4 days post-infection by measuring 
supernatant p24 antigen levels. In some experiments, cells under 1% O2 were re-oxygenated for the 
last 2 days of culture (Re-O2). (a) Viral replication over time in cells from different donors cultured 
in 20% O2. The results shown at each timepoint are the average supernatant p24 values from two 
replicate wells. Each line represents data from an individual donor (n=10). (b, c) Supernatant p24 
antigen levels in cells from each donor cultured under 20% or 1% O2 conditions after (b) 2 days of 
infection, or (c) 4 days of infection (n=7-10). (d) Supernatant p24 antigen levels in cells from each 
donor cultured for 4 days under 1% O2 or re-oxygenated for the last 2 days of culture (n=6). Each 
symbol represents data from an individual donor where two independent biological replicates were 
analysed. Paired samples are indicated (n=6-10, Wilcoxon matched-pairs signed rank test). (e) 
Spearman Correlation of levels of Glut-1 expression and HIV-1 replication (as extracellular p24 
antigen levels) under normoxic conditions relative to values in 20% O2 after 2 days of culture. Each 
symbol represents data from an individual donor. 
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Supplementary Figure 2. CD4 T cell viability and activation are not impaired under low oxygen 
tension. Activated CD8 depleted PBMC were incubated (without infection) under 20% or 1% O2 for 
2 or 4 days. (a) Cell viability was assessed on day 4 by flow cytometry using a live-dead stain, and 
the proportion of T cells within the live cell population was evaluated. Histogram plots illustrating 
staining of cells from one representative donor are shown on the left, and summary plots of the 
percentage of live cells and proportion of CD3+CD4+ and CD3+CD4- T cells and CD3- non-T cells 
within all live cells are shown on the right (n=10, mean + SEM, Wilcoxon matched-pairs signed rank 
test). (b, c) T cell activation was assessed by evaluating CD25, CD38, CD134, HLA-DR and PD-1 
expression on days 2 (b) and 4 (c). Histogram plots illustrating staining of cells from one 
representative donor at day 2 and day 4 are shown, and together with summarised data showing 
the percentage of cells expressing each marker within the live CD3+CD4+ population and level of 
intensity of staining (geometric mean fluorescence intensity (gMFI)) of this population at 2 and 4 
days post-activation (n=10, mean + SEM, Wilcoxon matched-pairs signed rank test). Each symbol 
represents data from one individual donor.  
 
Supplementary Figure 3. Low oxygen conditions have no effect on the early steps of viral life cycle 
and HIV integration events in 1G5 and TZM-bl cells. (a) 1G5 or (b) TZM-bl cells were infected with 
HIV NL4.3-Bal under 20% or 1% O2 for 48h. HIV strong stop, 1st and 2nd strand products along with 
the number of HIV integrated copies in the hypoxic cultures are expressed relative to the normoxic 
controls. Each symbol represents data from one biological replicate (n=4; mean ± SEM, Wilcoxon 
matched-pairs signed rank test). 
  
  
Supplementary Figure 4. Expression of pTAT in TZM-bl cells increases HIV-LTR activity; Low oxygen 
increases HRE promoter activity. (a) TZM-bl cells were transfected with a control plasmid or pTAT 
and LTR activity was assessed 24h later by evaluating luciferase expression in cell lysates and the 
data expressed relative to the normoxic controls (n = 5, mean ± SEM, Mann-Whitney analysis). (b) 
HRE-Luc reporter were transfected into Jurkat cells and cultured in 20% or 1% O2 conditions for 48h. 
Luciferase values (relative light units, RLU) are reported (n = 3, mean ± SEM). 
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Supplementary Figure 5. Evaluation of the effect of HIF silencing and NSC or DMOG treatment on 
cell viability. (a) Jurkat cells were cultured at 20% or 1% O2 with HIF-1α or HIF-2α silencing or 
treatment with DMOG or NSC. Cell viability was assessed after 24 hours by flow cytometry using a 
live-dead stain. Representative plots are shown on the left, and summarised data from cells from 4 
different experiments is shown on the right. (n=4, mean ± SEM, Kruskal-Wallis with Dunn’s MCA 
analysis). (b) Activated primary CD4 T cells were cultured at 20% or 1% O2 and treated with DMOG 
or NSC and cell viability was assessed after 24 hours by flow cytometry using a live-dead stain. 
Representative plots are shown on the left, and summarised data from cells from different donors 
is shown on the right (n=4; mean ± SEM, Wilcoxon matched-pairs signed rank test). 
  
  
Supplementary Figure 6. Effect of low oxygen on TNFα reactivation of HIV-1 in ACH2 cells. (a) ACH2 
cells cultured under 20% or 1% O2 conditions were assessed for HIF-1α expression by western 
blotting. (b) ACH2 cells were activated with TNFα under 20% or 1% O2 conditions and viral replication 
assessed 48h later by measuring extracellular p24 antigen or quantitative real-time PCR of HIV RNA 
and the data expressed relative to the normoxic controls (n = 3-6, mean + SEM, Unpaired t test). 
  
 
Supplementary Figure 7. HRE conservation in HIV-1 strains found in early infection. A search of the 
LANL database (April 2019) identified 84 sequences derived from patients sequenced in acute/early 
infection, as defined by a Fiebig score of 1-5, where LTR sequences were available. The sequences 
were derived from HIV-1 subtypes A (27), B (28), C (20) or D (5), with the remaining 5 sequences 
representing recombinant virus types. The image shows the same LTR region as depicted in Fig.5a 
and highlights that 43 of 84 sequences (51%) contained a conserved HRE.  
  
Supplementary Table 1. Primers used in study. Oligonucleotide sequences are listed below. Oligos 
used for mutagenesis are shown in lower case with the altered bases shown in bold. 
 Forward 5’ – 3’ Reverse 5’ – 3’ 
HIV strong stop 
oHC64 (TAACTAGGGAACCCACTGC) oHC65 (GCTAGAGATTTTCCACACTG) 
Taqman Probe oHC66 (FAM-ACACAACAGACGGGCACACACTA-BHQ1) 
HIV 1st strand 
HIV-fst-f1 (GAGCCCTCA GATCCTGCATAT) oHC65 (GCTAGAGATTTTCCACACTG) 
Taqman Probe oHC66 (FAM-ACACAACAGACGGGCACACACTA-BHQ1) 
HIV 2nd strand 
oHC64 (TAACTAGGGAACCCACTGC) gag-m661-as 
(CTGCGTCGAGAGAGCTCCTCTGGTT) 
Taqman Probe oHC66 (FAM-ACACAACAGACGGGCACACACTA-BHQ1) 
HIV integration 
Alu-F (GCCTCCCAAAGTGCTGGGATTACAG) gag-R (GTTCCTGCTATGTCACTTCC) 
LTR-F(TTAAGCCTCAATAAAGCTTGCC) LTR-R(GTTCGGGCGCCACTGCTAGA) 
Taqman Probe oHC66 (FAM-ACACAACAGACGGGCACACACTA-BHQ1) 
HIV RNA PATH-HIV1 KIT, PRIMER DESIGN LTD. UK  
HRE deletion atgcagctctcgggcatgaaatgctaggcg cgcctagcatttcatgcccgagagctgcat 
HRE mutant 1 atgcagctctcgggccatatgatgaaatgctaggcg cgcctagcatttcatcatatggcccgagagctgcat 
HRE mutant 2 ccggatgcagctctcgggctcacggatgaaatgctaggcggctg cagccgcctagcatttcatccgtgagcccgagagctgcatccgg 
HIF1β ChIP LTR-HRE TCGATGTCAGCAGTTCTTGAAGTA CCTGAGAGAGAAGTGTTAGAGTGG 
HIF1β ChIP LTR non-HRE GTAGTTCTGCCAATCAGGGAAGTA GACTTACAAGGCAGCTGTAGATCT 
HIF1β ChIP CA9 TCTCGTTTCCAATGCACGTACAGC AGTGACAGCAGCAGTTGCACAGT 
HIF1β ChIP VEGFA GGGAGCCCCTAGGCCACTA AGGCCGTGGACCCTGGTA  
HIF1β ChIP β-actin AGATGTGGATTAGCAAGCAGG GCTTATTCCAGTTTCGTGAGGC 
 
 
